NCT00909324 - Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery | Biotech Hunter

Enrollment

170

Participants

Timeline

Start Date

August 1, 2009

Primary Completion Date

January 1, 2010

Study Completion Date

January 1, 2010

Conditions

Dry Eye

Interventions

DRUG

Pre-LASIK 0.3% hypromellose

Patients self-administered GenTeal eye drops qid (quarter in die, 4 times a day) starting 5 days prior to LASIK surgery and continuing through 1 month after LASIK surgery.

DRUG

Post-LASIK 0.3% hypromellose

Patients self-administered GenTeal eye drops qid (quarter in die, 4 times a day) starting on the day of LASIK surgery and continuing through 1 month after surgery.

Trial Locations (1)

110088

Novartis Investigative Site, Delhi